首页> 中文期刊>国际医药卫生导报 >梅州市儿童支气管哮喘临床用药调查分析

梅州市儿童支气管哮喘临床用药调查分析

摘要

Objeotive To comprehend the use of Global Initiative for Asthma (GINA)in the treatment of children with bronchial asthma in Meizhou city;and to analyze the causes and the relevant strategies for better preventing and treating bronchial asthma.Methods A clinic survey on the therapies for 410 pediatric patients was conducted by using questionnaires.Results 39.8%of the patients were administered inhaled glucocorticoid and β-reeeptor agonists in the sudden onset of asthma,and 41.5%were administered intravenous corticosteroids and aminophyline.Only7.1%of the patients received regular inhaled glucocorticoid and 53.2%received no treatment in the remission phase.Conclusions The physicians in Meizhou adopt the GINA plan during the treatment ofacute bronchial asthma,but there has existed irrational drug use in medical practice because of insufficient understanding of the plan.The rate of GINA adoption,however,is still low.GINA shoud be further promoted in the treatment of bronchial asthma.%目的 了解梅州市目前治疗儿童哮喘过程中全球哮喘防治的创议(GINA)的应用情况,分析原因并提出相应对策,以便更好地开展哮喘防治工作.方法 对410名被确诊为支气管哮喘的门诊患儿及家属进行有关该患儿哮喘的治疗方式及其他相关情况的问卷调查.结果哮喘急性发作期采用吸入型糖皮质激素加β受体激动剂吸入的占39.8%,采用静脉滴注激素加氨茶碱的占41.5%;临床缓解期规则应用吸入型糖皮质激素吸入的仅占7.1%.不治疗的占53.2%.结论 我地区医生在哮喘急性发作期治疗中已经执行了GINA方案,但对方案的理解、认识不充分,在医疗实践中仍有不合理用药;而GINA方案在哮喘临床缓解期治疗中采用率非常低.今后哮喘防治工作应该继续推广GINA,做好儿童哮喘防治指南普及工作.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号